Sunday Riley A+ review: a blended percentage with several evidence layers

The official product name is A+ High-Dose Retinoid Serum. The US description advertises a 1 fl. oz., or 30 mL, option alongside separate 15 mL and 50 mL options. These are product presentations, not evidence that a particular size is supplied in every transaction or that the current contents of a recipient’s bottle have been verified. Manufacturer product information

The vehicle and strength guide explains why a serum label, an amount of contents and an active declaration answer different questions. For A+, the selected 30 mL presentation does not determine a personal quantity or duration of use. It is simply the advertised package considered in this review.

Sunday Riley describes a 6.5% solution composed of a 5% retinoid ester blend, a 1% liposomal-encapsulated retinol blend and 0.5% blue-green algae with retinoid-alternative activity. Those words identify blends and an extract component. They do not expressly establish that 6.5% of the serum is pure retinol or a single pure retinoid. Manufacturer product information

Keeping the units attached to the maker’s descriptions avoids a misleading numerical comparison. The Retinaldehyde Cream Serum review provides another preparation to examine separately. No concentration, release behavior or outcome is transferred between the two products, and a larger combined figure does not establish a universally preferable formula.

The FAQ instead says A+ combines 5% hydroxypinacolone retinoate with 1% liposome-encapsulated retinol. That is different wording from the main description’s ester blend and retinol blend. The reviewed material does not supply the analytical basis needed to reconcile those formulations. This article therefore does not choose one wording as a verified pure-ingredient concentration. Manufacturer product information

The combination-ingredient guide keeps the complete preparation separate from the substances highlighted to explain it. Here, the gap is quite specific: what amount and material does each percentage represent in the finished serum? A descriptive FAQ alone does not provide an assay or resolve the main page’s blend terminology.

The product account names Hawaiian white honey, bisabolol, cactus extract and ginger as part of a soothing explanation, and it includes fragrance-free wording. Those details identify selected ingredients and the manufacturer’s intentions. A complete INCI declaration for the exact preparation was not available in the product material reviewed here; that does not prove the brand lacks one elsewhere. Manufacturer product information

FTC explains why evidence about a constituent may not establish a benefit of a mixture containing other ingredients. Applied to A+, the question is how the complete current serum supports its comfort claims, rather than whether a highlighted constituent has a familiar reputation. The botanical account cannot predict personal tolerance or stand in for the full base. FTC ingredient-versus-mixture discussion

The manufacturer describes a study of 33 women assessed by an independent laboratory using a cutometer, silicone replica analysis and an expert grader. It attributes wrinkle-depth and width findings at four and six weeks to replica analysis. Those method names give more detail than a general claim of clinical testing, while remaining a public summary rather than the complete report. Manufacturer product information

The same account reports different timing for firmness, pores, redness and lines, including a six-week fine-line result. They should not be compressed into one universal response time or used as application advice. The Murad serum review is separate product navigation; its group and endpoints do not complete the missing methods for A+.

After one week, the summary says 96.97% of women agreed their skin appeared calmer. That is a participant impression, distinct from the wrinkle measurements described elsewhere. It should not be converted into a measured reduction in inflammation or an assurance that the formulation will feel comfortable for anyone who has experienced irritation. Manufacturer product information

The inspected summary does not provide its full comparator, protocol or every underlying measurement. FTC’s discussion of evidence type and claim strength helps preserve that boundary. Naming an independent lab does not make this publication an independent tester, and percentages about agreement should retain the question being asked rather than becoming broader clinical conclusions. FTC substantiation guidance

A+ supplies a named serum, advertised package options, a detailed blend narrative and a study summary with specified assessments. Its unresolved issues concern the percentage wording, the complete declaration and the supporting report’s methods. Those gaps do not erase the useful detail, but they prevent a review from authenticating or fully characterizing someone’s supplied bottle. Manufacturer product information

The container-question guide distinguishes a public presentation from accompanying information for an actual preparation. Here, neither the 30 mL listing nor the clinical summary establishes container condition or delivers a handling rule. The review ends with specific formula and evidence questions, without turning the high-dose name into a personal decision.